By assessing the isotypic pattern and serum concentration of ETX-reacting antibodies, our study brings new findings that reveal a predominant IgM response over IgG and IgA antibody responses both in MS patients and controls and, moreover, significantly higher levels of IgM reacting to ETX in MS patients compared to controls. The gene discussed is CD40LG; the disease is myeloid sarcoma.